EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spectrum of autoantibodies and other serological parameters in connective tissue disease–associated interstitial lung disease patients

Pooja Jaiswal, Tanya Athavale, Amita Athavale, Hemangini Thakkar, Ridi Khatri, Amrutha Jose, Trisha Samant, Tanaya Tipnis, Namrata Neman, Milind Nadkar, Anjali Rajadhyaksha, Manisha Madkaikar und 1 weitere

Frontiers in Medicine · 03.06.2026 · 13

DOI: 10.3389/fmed.2026.1812588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 03.06.2026. Verfasst von Pooja Jaiswal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical & Experimental Immunology, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Connective tissue disease–associated interstitial lung disease (CTD-ILD) is a major cause of morbidity and mortality in autoimmune disorders, yet detailed serological characterization remains limited in Indian cohorts.

Objective

This study aimed to evaluate and compare demographic, radiological, autoantibody, and serum profiles between CTD-ILD and non-CTD-ILD patients from Western India and to delineate hospitalization patterns and mortality outcomes among CTD-ILD patients.

Methods

This single-centre, cross-sectional study enrolled 200 patients with ILD ( n = 90 with CTD-ILD and n = 110 with non-CTD-ILD) from a tertiary care centre who were evaluated on a clinico-radiological basis. Antinuclear antibodies and ANA subspecificities were assessed using indirect immunofluorescence and a line blot assay. Serological parameters were quantified using ELISA and multiplex bead-based assays.

Results

CTD-ILD patients were significantly younger (49 vs. 57 years; p < 0.001) and predominantly female (80.0% vs. 59.1%; p = 0.002). NSIP predominated in CTD-ILD (51.1%), whereas UIP predominated in non-CTD-ILD (46.4%; p < 0.001). On multivariable analysis, younger age (aOR = 0.954; p < 0.001), female sex (aOR = 2.709; p = 0.023), NSIP (aOR = 6.155; p = 0.001), and UIP (aOR = 8.877; p < 0.001) were independent predictors of CTD-ILD. ANA positivity was higher in CTD-ILD (70.0% vs. 54.5%; p = 0.025), with a predominance of high-titre ANA (81.0%, ≥1:160) and a speckled IFA pattern. The nucleolar pattern was significantly more prevalent in the CTD-ILD group (11.1%; p = 0.010). Disease-specific autoantibody enrichment was observed as follows: anti-SSA/Ro and AMA-M2 in RA-ILD, anti-RNP/Sm in MCTD-ILD, and anti-Scl-70 in SSc-ILD. Anti-MDA5 ( p = 0.001), LDH ( p = 0.019), and pro-inflammatory cytokines TNF-α, IFN-γ, IL-4, and IL-22 were significantly elevated in CTD-ILD, whereas MMP7 levels were lower ( p = 0.025). TNF-α, IL-22, and IL-4 remained independent predictors in the multivariable analysis. Among CTD-ILD patients, 20.0% required hospitalization, with significantly higher in-hospital mortality in admitted patients (27.8% vs. 4.2%; p = 0.007) than in non-admitted CTD-ILD patients.

Conclusion

CTD-ILD patients demonstrated distinct demographic, radiological, autoantibody, and serological profiles compared to non-CTD-ILD patients, characterized by elevated anti-MDA5, LDH, and pro-inflammatory cytokines alongside lower MMP7 levels, reflecting an immune-driven rather than fibrosis-dominant pathobiology. These findings contribute to bridging the knowledge gap in the serological characterization of CTD-ILD in Indian cohorts.

Schlagwörter

Stichwörter der Autor:innen

ANA specificitiesCTD-ILDautoantibodiesconnective tissue diseases (CTD)interstitial lung disease (ILD)

Autor:innen und Institutionen

  • Department of Clinical & Experimental Immunology, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India.
  • Department of Pulmonary Medicine and Environmental Pollution Research Centre, Seth G. S. Medical College and King Edward Memorial Hospital, Mumbai, India.
  • Department of Radiology, Seth G. S. Medical College and King Edward Memorial Hospital, Mumbai, India.
  • ICMR-National Institute of Immunoheamatology, Mumbai, India.
  • Department of Medicine, Seth G. S. Medical College and King Edward Memorial Hospital, Mumbai, India.
  • Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.

Zitieren

APA

Jaiswal, P., Athavale, T., Athavale, A., Thakkar, H., Khatri, R., Jose, A., Samant, T., Tipnis, T., Neman, N., Nadkar, M., Rajadhyaksha, A., Madkaikar, M., & Pradhan, V. (2026). Spectrum of autoantibodies and other serological parameters in connective tissue disease–associated interstitial lung disease patients. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1812588

Vancouver

Jaiswal P, Athavale T, Athavale A, Thakkar H, Khatri R, Jose A, et al. Spectrum of autoantibodies and other serological parameters in connective tissue disease–associated interstitial lung disease patients. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1812588

BibTeX
@article{Jaiswal2026,
  author = {Jaiswal, Pooja and Athavale, Tanya and Athavale, Amita and Thakkar, Hemangini and Khatri, Ridi and Jose, Amrutha and Samant, Trisha and Tipnis, Tanaya and Neman, Namrata and Nadkar, Milind and Rajadhyaksha, Anjali and Madkaikar, Manisha and Pradhan, Vandana},
  title = {Spectrum of autoantibodies and other serological parameters in connective tissue disease–associated interstitial lung disease patients},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1812588}
}
Kostenlos starten →